Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 17

The DOI matches its Crossref record.

Comparison of the Structure and Function of Phospholamban and the Arginine-14 Deficient Mutant Associated with Dilated Cardiomyopathy

Hughes, Eleri, Middleton, David A. · 2014 · PLoS ONE

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0106746

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 47

  1. AD Wegener, 1984, Phosphorylation-induced mobility shift in phospholamban in sodium dodecyl sulfate-polyacrylamide gels - Evidence for a protein-structure consisting of multiple identical phosphorylatable subunits, J Biol Chem, 259, 1834, 10.1016/S0021-9258(17)43484-3 · DOI · Paper page
  2. J Fujii, 1987, Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban, J Clin Invest, 79, 301, 10.1172/JCI112799 · DOI · Paper page
  3. M Tada, 1983, Regulation of calcium transport by the ATPase-phospholamban system, J Mol Cell Cardiol, 15, 565, 10.1016/0022-2828(83)90267-5 · doi:10.1016/0022-2828(83)90267-5
  4. KL Koss, 1996, Phospholamban: A prominent regulator of myocardial contractility, Circ Res, 79, 1059, 10.1161/01.RES.79.6.1059 · DOI · Paper page
  5. P James, 1989, Nature and site of phospholamban regulation of the Ca-2+ pump of sarcoplasmic-reticulum, Nature, 342, 90, 10.1038/342090a0 · DOI · Paper page
  6. WA Jackson, 1996, Translation of Ser(16) and Thr(17) phosphorylation of phospholamban into Ca2+-pump stimulation, Biochem J, 316, 201, 10.1042/bj3160201 · DOI
  7. S Negash, 2000, Phospholamban remains associated with the Ca2+- and Mg2+- dependent ATPase following phosphorylation by cAMP-dependent protein kinase, Biochem J, 351, 195, 10.1042/bj3510195 · DOI
  8. Y Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J Biol Chem, 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
  9. SL Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circulation Research, 101, 1123, 10.1161/CIRCRESAHA.107.159947 · DOI
  10. R Verardi, 2011, Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method, Proceedings of the National Academy of Sciences of the United States of America, 108, 9101, 10.1073/pnas.1016535108 · DOI · Paper page
  11. J Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys J, 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI · Paper page
  12. NJ Traaseth, 2009, Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach, Proceedings of the National Academy of Sciences of the United States of America, 106, 10165, 10.1073/pnas.0904290106 · DOI · Paper page
  13. S Abu-Baker, 2007, The structural topology of wild-type phospholamban in oriented lipid bilayers using N-15 solid-state NMR spectroscopy, Protein Science, 16, 2345, 10.1110/ps.072977707 · DOI · Paper page
  14. M Gustavsson, 2011, Lipid-Mediated Folding/Unfolding of Phospholamban as a Regulatory Mechanism for the Sarcoplasmic Reticulum Ca(2+)-ATPase, Journal of Molecular Biology, 408, 755, 10.1016/j.jmb.2011.03.015 · DOI · Paper page
  15. LR Masterson, 2011, cAMP-Dependent Protein Kinase A Selects the Excited State of the Membrane Substrate Phospholamban, Journal of Molecular Biology, 412, 155, 10.1016/j.jmb.2011.06.041 · DOI · Paper page
  16. JP Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
  17. K Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proceedings of the National Academy of Sciences of the United States of America, 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  18. PA van der Zwaag, 2012, Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy, European Journal of Heart Failure, 14, 1199, 10.1093/eurjhf/hfs119 · DOI · Paper page
  19. KN Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proceedings of the National Academy of Sciences of the United States of America, 108, 2735
  20. JP Schmitt, 2009, Alterations of Phospholamban Function Can Exhibit Cardiotoxic Effects Independent of Excessive Sarcoplasmic Reticulum Ca2+-ATPase Inhibition, Circulation, 119, 436, 10.1161/CIRCULATIONAHA.108.783506 · DOI
  21. K Haghighi, 2012, The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase, Journal of Molecular and Cellular Cardiology, 52, 773, 10.1016/j.yjmcc.2011.11.012 · DOI · Paper page
  22. DK Ceholski, 2012, Lethal, Hereditary Mutants of Phospholamban Elude Phosphorylation by Protein Kinase A, Journal of Biological Chemistry, 287, 26596, 10.1074/jbc.M112.382713 · DOI · Paper page
  23. J East, 1982, Lipid selectivity of the Ca2+ and Mg2+ ion dependent adenosinetriphosphate studied with fluorescence quenching by a bromine phospholipid, Biochemistry, 21, 4144, 10.1021/bi00260a035 · DOI · Paper page
  24. B Buck, 2003, Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies, Protein Expression and Purification, 30, 253, 10.1016/S1046-5928(03)00127-X · DOI · Paper page
  25. JL Douglas, 2005, Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies, Protein Expr Purif, 40, 118, 10.1016/j.pep.2004.11.015 · doi:10.1016/j.pep.2004.11.015
  26. E Hughes, 2010, Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function, Biochemical and Biophysical Research Communications, 401, 370, 10.1016/j.bbrc.2010.09.056 · DOI
  27. J Hu, 2007, Structural biology of transmembrane domains: Efficient production and characterization of transmembrane peptides by NMR, Protein Science, 16, 2153, 10.1110/ps.072996707 · DOI
  28. KA Dalton, 1999, Anionic phospholipids decrease the rate of slippage on the Ca2+-ATPase of sarcoplasmic reticulum, Biochem J, 342, 431, 10.1042/bj3420431 · doi:10.1042/bj3420431
  29. D Levy, 1992, Reconstitution of the sarcoplasmic-reticulum Ca2+-Atpase - mechanisms of membrane-protein insertion into liposomes during reconstitution procedures involving the use of detergents, Biochim Biophys Acta, 1107, 283, 10.1016/0005-2736(92)90415-I · doi:10.1016/0005-2736(92)90415-i
  30. E Hughes, 2003, Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase, J Biol Chem, 278, 20835, 10.1074/jbc.M212208200 · doi:10.1074/jbc.m212208200
  31. T Toyofuku, 1994, Amino-acids Glu(2) to Ile(18) in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-Atpase of sarcoplasmic-reticulum, J Biol Chem, 269, 3088, 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
  32. A Yoda, 1970, On reversibility of binding cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphate from beef brain, Biochemical and Biophysical Research Communications, 40, 880, 10.1016/0006-291X(70)90985-X · doi:10.1016/0006-291x(70)90985-x
  33. LG Reddy, 2003, Defining the molecular components of calcium transport regulation in a reconstituted membrane system, Biochemistry, 42, 4585, 10.1021/bi026995a · DOI · Paper page
  34. M Li, 1998, Phosphorylation-induced structural change in phospholamban and its mutants, detected by intrinsic fluorescence, Biochemistry, 37, 7869, 10.1021/bi9801053 · DOI
  35. P Cook, 1982, Adenosine cyclic 3', 5' - monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit, Biochemistry, 21, 5794, 10.1021/bi00266a011 · DOI · Paper page
  36. DK Ceholski, 2012, Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy, Journal of Biological Chemistry, 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
  37. OC Andronesi, 2005, Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy, Journal of the American Chemical Society, 127, 12965, 10.1021/ja0530164 · DOI · Paper page
  38. E Hughes, 2009, Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: A new role for phospholipids in the regulation of cardiac calcium cycling?, Biochimica Et Biophysica Acta-Biomembranes, 1788, 559, 10.1016/j.bbamem.2008.10.029 · doi:10.1016/j.bbamem.2008.10.029
  39. G Hughes, 1996, An investigation of the mechanism of inhibition of the Ca2+- ATPase by phospholamban, Biochem J, 318, 973, 10.1042/bj3180973 · DOI
  40. JR Waggoner, 2007, Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate, Biochemistry, 46, 1999, 10.1021/bi061365k · DOI
  41. T Cantilina, 1993, Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+, J Biol Chem, 268, 17018, 10.1016/S0021-9258(19)85295-X · DOI · Paper page
  42. BL Akin, 2010, Superinhibitory Phospholamban Mutants Compete with Ca2+ for Binding to SERCA2a by Stabilizing a Unique Nucleotide-dependent Conformational State, Journal of Biological Chemistry, 285, 28540, 10.1074/jbc.M110.151779 · DOI · Paper page
  43. EL Lockamy, 2011, Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure, Biochemical and Biophysical Research Communications, 408, 388, 10.1016/j.bbrc.2011.04.023 · DOI
  44. SJ Gruber, 2012, Phospholamban mutants compete with wild type for SERCA binding in living cells, Biochemical and Biophysical Research Communications, 420, 236, 10.1016/j.bbrc.2012.02.125 · doi:10.1016/j.bbrc.2012.02.125
  45. JE Mahaney, 2000, Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: New insights on Ca-ATPase regulation by phospholamban, Biophys J, 78, 1306, 10.1016/S0006-3495(00)76686-0 · doi:10.1016/s0006-3495(00)76686-0
  46. E Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J Biol Chem, 275, 14985, 10.1074/jbc.275.20.14985 · DOI
  47. M Sayadi, 2010, Effect of Membrane Thickness on Conformational Sampling of Phospholamban from Computer Simulations, Biophysical Journal, 98, 805, 10.1016/j.bpj.2009.11.015 · DOI

Cited by

See all 17

Metadata

Authors
Hughes, E., & Middleton, D. A.
Venue
PLoS ONE
Published
2014-09-16
Volume
9
Issue
9
Pages
e106746
ISSN
1932-6203
Cited by
17
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of the Structure and Function of Phospholamban and the Arginine-14 Deficient Mutant Associated with Dilated Cardiomyopathy. https://app.cochat.ai/papers/10.1371/journal.pone.0106746
The paper
Hughes, E., & Middleton, D. A. (2014). Comparison of the Structure and Function of Phospholamban and the Arginine-14 Deficient Mutant Associated with Dilated Cardiomyopathy. PLoS ONE. https://doi.org/10.1371/journal.pone.0106746

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.